Metagenomi, Inc. (MGX)
NASDAQ (NGS) NASDAQ (NGS) Primary 
An Inquiry Into Metagenomi Inc Has Been Opened By The Schall Law Firm For Possible Securities Fraud And Shareholders Are Encouraged To Participate
LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
ATTENTION MGX SHAREHOLDERS: Investors Who Lost Money on Metagenomi, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Metagenomi Inc Is Being Investigated By The Schall Law Firm For Potential Securities Laws Violations And Urges Investors To Join
LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
Metagenomi Being Investigated on Behalf of Metagenomi, Inc. Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
The Schall Law Firm Is Investigating Metagenomi Inc For Violations Of Securities Laws And Encourages Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Metagenomi, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Metagenomi (MGX)
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
The Schall Law Firm Is Looking Into Violations Of Securities Laws By Metagenomi Inc And Invites Investor Participation
LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Metagenomi, Inc. - MGX
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or the "Company") (NASDAQ:MGX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
MGX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Metagenomi, Inc. investment
NEW YORK, NY / ACCESSWIRE / August 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
The Schall Law Firm Is Investigating Metagenomi Inc For Securities Fraud And Urges Shareholder Participation
LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or "the Company") (NASDAQ:MGX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
MGX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Metagenomi, Inc.
NEW YORK, NY / ACCESSWIRE / August 17, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Metagenomi, Inc. ("Metagenomi") (NASDAQ:MGX) concerning possible violations of federal securities laws. On May 1, 2024, Metagenomi surprisingly announced the "Mutual termination of Moderna Collaboration.
